Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TYRA compared with JANX: revenue, margins and what each company keeps, and the suppliers and customers both name
TYRA
Tyra Biosciences, Inc.
Change
Mkt cap
Revenue
Revenue
JANX
Janux Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
TYRA
Tyra Biosciences, Inc.
vs
JANX
Janux Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only TYRA
0
None
Shared
0
No disclosed counterparties: TYRA.
Only JANX
1
MRK
Merck Sharp & Dohme
customer
Role chip = supplier or customer
Source: SEC EDGAR
TYRA
Tyra Biosciences, Inc.
Change
21.07
▲
+0.88%
Mkt cap
$1.2B
Revenue
—
JANX
Janux Therapeutics, Inc.
Change
17.30
▲
+7.75%
Regular session
Nov 6 '26
Mkt cap
$982.6M
Revenue
$9M
Q3 FY26
vs
Compare
Regular session
Nov 6 '26
TYRA
Tyra Biosciences, Inc.
vs
JANX
Janux Therapeutics, Inc.
21.07
▲
+0.88%
Price
17.30
▲
+7.75%
$1.2B
Mkt cap
$982.6M
—
Revenue
$9M
Q3 FY26
Change
Change
TYRA
21.07
▲
+0.88%
vs
JANX
17.30
▲
+7.75%
Regular session
Nov 6 '26